We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$494M
AUM Growth
+$7.76M
Cap. Flow
-$29.3M
Cap. Flow %
-5.94%
Top 10 Hldgs %
20.46%
Holding
182
New
33
Increased
22
Reduced
93
Closed
26

Top Buys

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$7.31M
2
HP icon
Helmerich & Payne
HP
+$7.02M
3
HELE icon
Helen of Troy
HELE
+$6.79M
4
MGRC icon
McGrath RentCorp
MGRC
+$6.5M
5
RBC icon
RBC Bearings
RBC
+$4.9M

Sector Composition

Rank Sector Weight
1 Industrials 18.3%
2 Financials 16.9%
3 Healthcare 13.86%
4 Technology 12.03%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
151
Repligen
RGEN
$9.25B
$218K 0.04%
1,289
-14
-1% -$2.54K
ODFL icon
152
Old Dominion Freight Line
ODFL
$44.9B
$213K 0.04%
+1,500
New +$213K
DAR icon
153
Darling Ingredients
DAR
$9.44B
$212K 0.04%
+3,391
New +$239K
GPK icon
154
Graphic Packaging
GPK
$3.58B
$208K 0.04%
+9,355
New +$206K
KSA icon
155
iShares MSCI Saudi Arabia ETF
KSA
$621M
$207K 0.04%
+5,487
New +$222K
IJR icon
156
iShares Core S&P Small-Cap ETF
IJR
$112B
$204K 0.04%
+2,160
New +$207K
APLS
157
DELISTED
Apellis Pharmaceuticals
APLS
-22,880
Closed -$1.56M
ASAN icon
158
Asana
ASAN
$2.13B
-64,485
Closed -$1.43M
AZTA icon
159
Azenta
AZTA
$1.48B
-50,368
Closed -$2.16M
BLFS icon
160
BioLife Solutions
BLFS
$1.7B
-100,820
Closed -$2.29M
CRSP icon
161
CRISPR Therapeutics
CRSP
$5.17B
-28,733
Closed -$1.88M
FATE icon
162
Fate Therapeutics
FATE
$326M
-72,304
Closed -$1.62M
FIVN icon
163
FIVE9
FIVN
$2.54B
-3,320
Closed -$249K
JKHY icon
164
Jack Henry & Associates
JKHY
$11.1B
-1,121
Closed -$204K
MZTI
165
The Marzetti Company
MZTI
$3.11B
-22,735
Closed -$3.42M
MRVI icon
166
Maravai LifeSciences
MRVI
$919M
-106,800
Closed -$2.73M
NTLA icon
167
Intellia Therapeutics
NTLA
$1.67B
-20,119
Closed -$1.13M
ONTO icon
168
Onto Innovation
ONTO
$15.3B
-34,674
Closed -$2.22M
POOL icon
169
Pool Corp
POOL
$7.5B
-1,315
Closed -$418K
RLMD icon
170
Relmada Therapeutics
RLMD
$527M
-37,570
Closed -$1.39M
RRX icon
171
Regal Rexnord
RRX
$11.9B
-2,669
Closed -$375K
SLG icon
172
SL Green Realty
SLG
$3.99B
-38,613
Closed -$1.55M
STAA icon
173
STAAR Surgical
STAA
$1.21B
-26,860
Closed -$1.9M
TREX icon
174
Trex
TREX
$5.01B
-5,903
Closed -$259K
TTGT icon
175
TechTarget
TTGT
$278M
-36,253
Closed -$2.15M

Similar funds

Moody Aldrich Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Moody Aldrich Partners held 182 positions worth $494M, up 1.6% from $486M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Moody Aldrich Partners withdrew a net $29.3M in Q4 2022, closing 26 positions and reducing 93 holdings. Its most notable exit was Zurn Elkay Water Solutions, an estimated $4.25M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Moody Aldrich Partners opened a new position in TEGNA Inc worth $7.69M.

  • Moody Aldrich Partners's largest Q4 2022 buy was TEGNA Inc: 362,774 shares worth $7.69M.
  • Moody Aldrich Partners added most to RBC Bearings in Q4 2022, an estimated $4.9M increase.
  • Moody Aldrich Partners's biggest Q4 2022 reduction was Independent Bank, cutting an estimated $4.95M.
  • Moody Aldrich Partners fully exited Zurn Elkay Water Solutions in Q4 2022, selling an estimated $4.25M.
  • Moody Aldrich Partners's ten largest holdings make up 20% of its $494M portfolio in Q4 2022.
  • Moody Aldrich Partners opened 33 new positions and closed 26 in Q4 2022.
  • Moody Aldrich Partners's portfolio value rose 1.6% quarter-over-quarter to $494M.

Based on Moody Aldrich Partners's 13F filing for Q4 2022, filed 24 Jan 2023.